Hi, I'm Dan Pramack, and welcome to Axios Recap, presented by General Motors.

Today is Monday, April 26th. Apple is opening up in North Carolina.

New Netflix sign-ups are down, and we're beginning to get pretty worried about vaccine hesitancy.

Vaccinating America was supposed to be about degrees of difficulty in descending order.

Developing vaccines for a novel virus? Well, that obviously had to come first and was supposed

to be the hardest part. But it got done in record time. Figuring out distribution logistics

came next, and despite some early hiccups, has been a screaming

success, as every single American adult is now legally eligible and 37 percent are fully vaccinated.

The third part, achieving herd immunity? Well, that was kind of supposed to be the third

and easiest step. Sure, there would be some holdouts, people scared off of this or that,

but if the vaccines were made, approved, and available, most people would take them,

and life could get back to normal. Except that's not quite how it's working out. Lots of people

are simply not getting vaccinated, with many states reporting more supply than demand. The U.S.

Department of Health and Human Services recently published what it called its vaccine

hesitancy map, showing, for example, that 30% of people in Mississippi say they're unwilling

to get jabbed. Nine other states, including Kansas and Georgia, came in at 25% or higher hesitancy.

Meanwhile, the CDC, just over the weekend, reported that 8% of Americans who got their first

dose of Pfizer or Moderna missed their appointment for a second one.

All of this matters because none of these vaccines are 100% effective, so everyone is put

at heightened risk for infection by those who don't get vaccinated.

Moreover, a lack of vaccination can increase the possibility of new variants.

And increased variance means an increased possibility that one could break through the vaccines.

...